Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug

Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic tar...

Full description

Saved in:
Bibliographic Details
Published inOncogenesis (New York, NY) Vol. 2; no. 8; p. e66
Main Authors Tamminen, J A, Parviainen, V, Rönty, M, Wohl, A P, Murray, L, Joenväärä, S, Varjosalo, M, Leppäranta, O, Ritvos, O, Sengle, G, Renkonen, R, Myllärniemi, M, Koli, K
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2013
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic target for mesothelioma. We found high expression levels of gremlin-1 in the mesothelioma tumor tissue, as well as in primary mesothelioma cells cultured from pleural effusion samples. Downregulation of gremlin-1 expression by siRNA-mediated silencing in a mesothelioma cell line inhibited cell proliferation. This was associated with downregulation of the transcription factor slug as well as mesenchymal proteins linked to cancer epithelial-to-mesenchymal transition. Further, resistance to paclitaxel-induced cell death was associated with high gremlin-1 and slug expression. Treatment of gremlin-1-silenced mesothelioma cells with paclitaxel or pemetrexed resulted in efficient loss of cell survival. Finally, our data suggest that concomitant upregulation of fibrillin-2 in mesothelioma provides a mechanism for extracellular localization of gremlin-1 to the tumor microenvironment. This was supported by the demonstration of interactions between gremlin-1, and fibrillin-1 and -2 peptides as well as by colocalization of gremlin-1 to fibrillin microfibrils in cells and tumor tissue samples. Our data suggest that gremlin-1 is also a potential target for overcoming drug resistance in mesothelioma.
AbstractList Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morphogenetic protein inhibitor crucial for embryonic development, as a potential therapeutic target for mesothelioma. We found high expression levels of gremlin-1 in the mesothelioma tumor tissue, as well as in primary mesothelioma cells cultured from pleural effusion samples. Downregulation of gremlin-1 expression by siRNA-mediated silencing in a mesothelioma cell line inhibited cell proliferation. This was associated with downregulation of the transcription factor slug as well as mesenchymal proteins linked to cancer epithelial-to-mesenchymal transition. Further, resistance to paclitaxel-induced cell death was associated with high gremlin-1 and slug expression. Treatment of gremlin-1-silenced mesothelioma cells with paclitaxel or pemetrexed resulted in efficient loss of cell survival. Finally, our data suggest that concomitant upregulation of fibrillin-2 in mesothelioma provides a mechanism for extracellular localization of gremlin-1 to the tumor microenvironment. This was supported by the demonstration of interactions between gremlin-1, and fibrillin-1 and -2 peptides as well as by colocalization of gremlin-1 to fibrillin microfibrils in cells and tumor tissue samples. Our data suggest that gremlin-1 is also a potential target for overcoming drug resistance in mesothelioma.
Author Myllärniemi, M
Murray, L
Varjosalo, M
Rönty, M
Koli, K
Renkonen, R
Tamminen, J A
Wohl, A P
Ritvos, O
Sengle, G
Parviainen, V
Joenväärä, S
Leppäranta, O
Author_xml – sequence: 1
  givenname: J A
  surname: Tamminen
  fullname: Tamminen, J A
  organization: Research Programs Unit, Translational Cancer Biology, University of Helsinki, Transplantation Laboratory, Haartman Institute, University of Helsinki
– sequence: 2
  givenname: V
  surname: Parviainen
  fullname: Parviainen, V
  organization: Transplantation Laboratory, Haartman Institute, University of Helsinki
– sequence: 3
  givenname: M
  surname: Rönty
  fullname: Rönty, M
  organization: Helsinki University Central Hospital and Hospital Laboratory, Department of Pathology, University of Helsinki
– sequence: 4
  givenname: A P
  surname: Wohl
  fullname: Wohl, A P
  organization: Center for Biochemistry, Medical Faculty, University of Cologne
– sequence: 5
  givenname: L
  surname: Murray
  fullname: Murray, L
  organization: Research Programs Unit, Translational Cancer Biology, University of Helsinki, Transplantation Laboratory, Haartman Institute, University of Helsinki
– sequence: 6
  givenname: S
  surname: Joenväärä
  fullname: Joenväärä, S
  organization: Transplantation Laboratory, Haartman Institute, University of Helsinki
– sequence: 7
  givenname: M
  surname: Varjosalo
  fullname: Varjosalo, M
  organization: Institute of Biotechnology, University of Helsinki
– sequence: 8
  givenname: O
  surname: Leppäranta
  fullname: Leppäranta, O
  organization: Division of Pulmonary Medicine, Department of Medicine, University of Helsinki
– sequence: 9
  givenname: O
  surname: Ritvos
  fullname: Ritvos, O
  organization: Helsinki University Central Hospital and Hospital Laboratory, Department of Bacteriology and Immunology, University of Helsinki
– sequence: 10
  givenname: G
  surname: Sengle
  fullname: Sengle, G
  organization: Center for Biochemistry, Medical Faculty, University of Cologne
– sequence: 11
  givenname: R
  surname: Renkonen
  fullname: Renkonen, R
  organization: Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki University Central Hospital and Hospital Laboratory
– sequence: 12
  givenname: M
  surname: Myllärniemi
  fullname: Myllärniemi, M
  organization: Division of Pulmonary Medicine, Department of Medicine, University of Helsinki
– sequence: 13
  givenname: K
  surname: Koli
  fullname: Koli, K
  email: katri.koli@helsinki.fi
  organization: Research Programs Unit, Translational Cancer Biology, University of Helsinki, Transplantation Laboratory, Haartman Institute, University of Helsinki
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23978876$$D View this record in MEDLINE/PubMed
BookMark eNptkU1r3DAQhkVJSNIk1x6LoJdevNGHZVuXQgltWgj0kruQtbKtIEtbjbyl5_7xauskbEuFQBrmmVczel-jkxCDRegNJRtKeHcTgwEHG0Yo3zD5Cl0wKtpKElafHN3P0TXAIylLNLQR4gydMy7brmubC_TrLtnZu1BRrAGicTpbwD9cnvDg-uR8yeHZmRTXEHCJ924fsQ5bnOy4-D8Vs4WYJ-tdnDU21nsMSyqc9jhPKS7jhHPSAUxyu-xiwIM2OSYMfhmv0OmgPdjrp_MSPXz-9HD7pbr_dvf19uN9ZWpJc9X3AxHUym5gjbC95rwnUm5rXpO6NdLKvuNSE0N1qztpyVCXXRNNOGkIo_wSfVhld0s_262xoXTk1S65WaefKmqn_s4EN6kx7hVvhaSsKwLvnwRS_L5YyGp2cJhVBxsXULSVRDbFGVbQd_-gj3FJoUxXqK7jQlBx6GizUuV7AZIdXpqhRB0cVqvD6uCwYrIUvD0e4QV_9rMANysAJRVGm47e_b_kb0hPuCs
CitedBy_id crossref_primary_10_1042_BSR20200164
crossref_primary_10_1155_2014_802841
crossref_primary_10_2139_ssrn_4128861
crossref_primary_10_1016_j_semcdb_2018_07_016
crossref_primary_10_1074_jbc_AC119_010148
crossref_primary_10_18632_oncotarget_8434
crossref_primary_10_3390_biomedicines10020301
crossref_primary_10_1038_s41416_020_0945_0
crossref_primary_10_1016_j_matbio_2015_05_002
crossref_primary_10_1371_journal_pone_0159010
crossref_primary_10_3390_ijms21113888
crossref_primary_10_18632_oncotarget_3118
crossref_primary_10_3390_ijms21176342
crossref_primary_10_1038_s41388_018_0153_z
crossref_primary_10_15616_BSL_2018_24_4_285
crossref_primary_10_3389_fphar_2019_00532
crossref_primary_10_1016_j_tcb_2014_12_004
crossref_primary_10_1016_j_bbrc_2020_10_025
crossref_primary_10_1002_pro_2485
crossref_primary_10_1016_j_yexcr_2014_12_010
crossref_primary_10_1007_s00018_021_03964_x
crossref_primary_10_18632_oncotarget_21550
crossref_primary_10_3390_cancers12082149
crossref_primary_10_1016_j_yexcr_2020_111941
crossref_primary_10_3389_fonc_2022_968610
crossref_primary_10_1074_jbc_M114_628412
crossref_primary_10_1038_s41598_018_28297_x
crossref_primary_10_1152_ajprenal_00344_2016
crossref_primary_10_1186_s12935_019_0852_8
crossref_primary_10_1016_j_mbplus_2021_100071
crossref_primary_10_1007_s13277_015_4093_8
Cites_doi 10.1111/j.1600-0463.2012.02931.x
10.1016/j.cell.2009.11.007
10.1073/pnas.0606857103
10.1038/onc.2008.232
10.1167/iovs.07-0086
10.1242/dev.01251
10.3816/CLC.2009.n.014
10.1074/jbc.M406696200
10.1016/j.yexcr.2011.04.006
10.1093/carcin/bgn274
10.1093/carcin/bgr110
10.1016/j.bone.2008.06.016
10.1007/978-1-60761-842-3_11
10.1371/journal.pone.0042264
10.1074/jbc.M210611200
10.1164/rccm.200706-945OC
10.1128/MCB.17.8.4801
10.1371/journal.pone.0035100
10.1073/pnas.0707210104
10.1016/j.ceb.2009.05.005
10.1183/09031936.00077309
10.1126/science.2153315
10.1038/nmeth.2400
10.1182/blood-2010-06-291930
10.2353/ajpath.2006.051263
10.1038/msb.2008.75
10.1007/s00441-012-1385-9
10.1186/gb-2008-9-9-r139
10.1038/modpathol.2011.144
10.1002/jcb.24094
10.1016/S0070-2153(06)75001-3
10.1016/S0006-291X(02)00828-8
10.1007/s00441-009-0822-x
10.1038/nrc2620
10.1074/jbc.M707820200
10.1016/j.ctrv.2012.03.001
10.1016/j.transproceed.2008.02.064
10.1038/labinvest.2010.49
10.1152/ajpendo.00389.2012
10.1016/S1097-2765(00)80067-2
10.1016/j.cell.2008.03.027
10.1007/s10911-010-9178-9
10.1186/1471-2407-6-74
10.1186/1471-2407-12-91
10.1016/j.yexcr.2005.08.008
10.1016/j.cellsig.2011.08.010
10.1074/jbc.275.12.8785
10.1002/ajim.20282
10.1016/j.stem.2007.11.009
ContentType Journal Article
Copyright The Author(s) 2013
Copyright Nature Publishing Group Aug 2013
Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2013
– notice: Copyright Nature Publishing Group Aug 2013
– notice: Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited
DBID C6C
NPM
AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7TO
H94
5PM
DOI 10.1038/oncsis.2013.29
DatabaseName Springer_OA刊
PubMed
CrossRef
ProQuest Central (Corporate)
PHMC-Proquest健康医学期刊库
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Science Database
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitleList Oncogenes and Growth Factors Abstracts

Publicly Available Content Database
PubMed

Database_xml – sequence: 1
  dbid: C6C
  name: Springer_OA刊
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Gremlin in mesothelioma cell survival
EISSN 2157-9024
EndPage e66
ExternalDocumentID 4053348331
10_1038_oncsis_2013_29
23978876
Genre Journal Article
GroupedDBID 0R~
3V.
53G
5VS
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBLON
EBS
EJD
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IPNFZ
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNT
RNTTT
RPM
SNYQT
UKHRP
NPM
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7TO
H94
5PM
ID FETCH-LOGICAL-c491t-bbf051e98f265eba33b099d434047c9e9b839a0c1a7a89e0f40f440a03060213
IEDL.DBID RPM
ISSN 2157-9024
IngestDate Tue Sep 17 21:22:30 EDT 2024
Fri Oct 25 05:06:53 EDT 2024
Thu Oct 10 17:19:01 EDT 2024
Fri Aug 23 03:15:26 EDT 2024
Sat Sep 28 07:52:43 EDT 2024
Fri Oct 11 20:34:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords gremlin
mesothelioma
EMT
fibrillin
slug
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c491t-bbf051e98f265eba33b099d434047c9e9b839a0c1a7a89e0f40f440a03060213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759128/
PMID 23978876
PQID 1788355151
PQPubID 2041913
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3759128
proquest_miscellaneous_1790961032
proquest_journals_1788355151
crossref_primary_10_1038_oncsis_2013_29
pubmed_primary_23978876
springer_journals_10_1038_oncsis_2013_29
PublicationCentury 2000
PublicationDate 2013-08-01
PublicationDateYYYYMMDD 2013-08-01
PublicationDate_xml – month: 08
  year: 2013
  text: 2013-08-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
– name: New York
PublicationTitle Oncogenesis (New York, NY)
PublicationTitleAbbrev Oncogenesis
PublicationTitleAlternate Oncogenesis
PublicationYear 2013
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Fassina, Cappellesso, Guzzardo, Dalla Via, Piccolo, Ventura (CR43) 2012; 25
Haslehurst, Koti, Dharsee, Nuin, Evans, Geraci (CR19) 2012; 12
Lee, O’Meara, O’Brien, Kane (CR41) 2007; 48
Shih, Yang (CR42) 2011; 32
Ramirez, Rifkin (CR27) 2009; 21
Merikallio, Pääkko, Salmenkivi, Kinnula, Harju, Soini (CR44) 2012; 121
Namkoong, Shin, Kim, Ha, Cho, Hur (CR12) 2006; 6
Leppäranta, Sens, Salmenkivi, Kinnula, Keski-Oja, Myllärniemi (CR24) 2012; 348
Ke, Reddel, Gerwin, Reddel, Somers, McMenamin (CR47) 1989; 134
Koli, Myllärniemi, Vuorinen, Salmenkivi, Ryynänen, Kinnula (CR16) 2006; 169
Kim, Yoon, Lee, Ha, Kim, Kim (CR33) 2012; 7
Ramirez, Sakai (CR15) 2010; 339
Lin, Tiedemann, Vollbrandt, Peters, Batge, Brinckmann (CR26) 2002; 277
Kilpinen, Autio, Ojala, Iljin, Bucher, Sara (CR37) 2008; 9
Koli, Ryynänen, Keski-Oja (CR48) 2008; 43
Michos, Panman, Vintersten, Beier, Zeller, Zuniga (CR10) 2004; 131
Mossman, Bignon, Corn, Seaton, Gee (CR1) 1990; 247
Polyak, Weinberg (CR21) 2009; 9
Myllärniemi, Lindholm, Ryynänen, Kliment, Salmenkivi, Keski-Oja (CR49) 2008; 177
Gordon, Kirkbride, How, Blobe (CR30) 2009; 30
Mulvihill, Kwon, Lee, Fang, Choi, Ray (CR34) 2012; 7
Mani, Guo, Liao, Eaton, Ayyanan, Zhou (CR20) 2008; 133
Pasello, Ceresoli, Favaretto (CR45) 2013; 39
Topol, Bardot, Zhang, Resau, Huillard, Marx (CR8) 2000; 275
Vancheri, Failla, Crimi, Raghu (CR25) 2010; 35
Tamminen, Myllärniemi, Hyytiäinen, Keski-Oja, Koli (CR53) 2012; 113
Fenyo, Eriksson, Beavis (CR51) 2010; 673
Vorobiof, Mafafo (CR4) 2009; 10
Huuskonen, Rantanen (CR3) 2006; 49
Carvajal, Droguett, Burgos, Aros, Ardiles, Flores (CR40) 2008; 40
Sneddon, Zhen, Montgomery, van de Rijn, Tward, West (CR13) 2006; 103
Sneddon, Werb (CR35) 2007; 1
Wang, Zhang, Wen, Zheng, Lazarovici, Jiang (CR39) 2012; 24
Dallas, Chen, Sivakumar (CR28) 2006; 75
Hsu, Economides, Wang, Eimon, Harland (CR7) 1998; 1
Mitola, Ravelli, Moroni, Salvi, Leali, Ballmer-Hofer (CR46) 2010; 116
Brinckmann, Hunzelmann, Kahle, Rohwedel, Kramer, Gibson (CR23) 2010; 90
Micalizzi, Farabaugh, Ford (CR6) 2010; 15
Varjosalo, Sacco, Stukalov, van Drogen, Planyavsky, Hauri (CR14) 2013; 10
Thiery, Acloque, Huang, Nieto (CR17) 2009; 139
Wang, Zhi, Zhang, Jiang, Liu, Han (CR22) 2012; 27
Koli, Hyytiäinen, Ryynänen, Keski-Oja (CR29) 2005; 310
Chen, Athanasiou, Gu, Blair (CR38) 2002; 295
Kang, Oh, Lee, Kang, Kim, Kim (CR31) 2011; 317
Sengle, Charbonneau, Ono, Sasaki, Alvarez, Keene (CR9) 2008; 283
Catalano, Rodilossi, Rippo, Caprari, Procopio (CR18) 2004; 279
Dormoy, Jacqmin, Lang, Massfelder (CR5) 2012; 32
Topol, Marx, Laugier, Bogdanova, Boubnov, Clausen (CR11) 1997; 17
Glatter, Wepf, Aebersold, Gstaiger (CR50) 2009; 5
Katsuno, Hanyu, Kanda, Ishikawa, Akiyama, Iwase (CR32) 2008; 27
Kosinski, Li, Chan, Zhang, Ho, Tsui (CR36) 2007; 104
Hulmi, Oliveira, Silvennoinen, Hoogaars, Ma, Pierre (CR52) 2013; 304
Lanphear, Buncher (CR2) 1992; 34
20490631 - J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34
15201225 - Development. 2004 Jul;131(14):3401-10
2153315 - Science. 1990 Jan 19;247(4940):294-301
17724219 - Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4291-9
12399449 - J Biol Chem. 2002 Dec 27;277(52):50795-804
2541616 - Am J Pathol. 1989 May;134(5):979-91
18455002 - Transplant Proc. 2008 Apr;40(3):734-9
23030626 - APMIS. 2013 Jan;121(1):1-10
22870311 - PLoS One. 2012;7(8):e42264
20195245 - Lab Invest. 2010 May;90(5):739-52
22429801 - BMC Cancer. 2012 Mar 19;12 :91
9234736 - Mol Cell Biol. 1997 Aug;17(8):4801-10
19513754 - Cell Tissue Res. 2010 Jan;339(1):71-82
21570392 - Exp Cell Res. 2011 Jul 15;317(12):1746-62
21906675 - Cell Signal. 2012 Jan;24(1):17-24
22993298 - Anticancer Res. 2012 Sep;32(9):3609-17
22514712 - PLoS One. 2012;7(4):e35100
16157329 - Exp Cell Res. 2005 Nov 1;310(2):370-82
22573546 - J Cell Biochem. 2012 Jul;113(7):2234-47
18371402 - Cell Stem Cell. 2007 Dec 13;1(6):607-11
18672106 - Bone. 2008 Oct;43(4):679-88
19262571 - Nat Rev Cancer. 2009 Apr;9(4):265-73
19362954 - Clin Lung Cancer. 2009 Mar;10(2):112-7
16470550 - Am J Ind Med. 2006 Mar;49(3):215-20
22434388 - Cell Tissue Res. 2012 Jun;348(3):491-503
20660291 - Blood. 2010 Nov 4;116(18):3677-80
16816361 - Am J Pathol. 2006 Jul;169(1):61-71
18663362 - Oncogene. 2008 Oct 23;27(49):6322-33
21935575 - Oncol Rep. 2012 Jan;27(1):58-64
19525102 - Curr Opin Cell Biol. 2009 Oct;21(5):616-22
16984808 - Curr Top Dev Biol. 2006;75:1-24
19056927 - Carcinogenesis. 2009 Feb;30(2):238-48
20835799 - Methods Mol Biol. 2010;673:189-202
19156129 - Mol Syst Biol. 2009;5:237
19945376 - Cell. 2009 Nov 25;139(5):871-90
17003113 - Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14842-7
23455922 - Nat Methods. 2013 Apr;10(4):307-14
10722723 - J Biol Chem. 2000 Mar 24;275(12):8785-93
12135612 - Biochem Biophys Res Commun. 2002 Aug 2;295(5):1135-41
18485877 - Cell. 2008 May 16;133(4):704-15
18339631 - J Biol Chem. 2008 May 16;283(20):13874-88
17975199 - Am J Respir Crit Care Med. 2008 Feb 1;177(3):321-9
18803840 - Genome Biol. 2008;9(9):R139
1494965 - J Occup Med. 1992 Jul;34(7):718-21
15337769 - J Biol Chem. 2004 Nov 5;279(45):46706-14
23115080 - Am J Physiol Endocrinol Metab. 2013 Jan 1;304(1):E41-50
21983934 - Mod Pathol. 2012 Jan;25(1):86-99
17881565 - Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15418-23
22459200 - Cancer Treat Rev. 2013 Feb;39(1):10-7
20190329 - Eur Respir J. 2010 Mar;35(3):496-504
21665887 - Carcinogenesis. 2011 Sep;32(9):1299-304
16545136 - BMC Cancer. 2006 Mar 18;6:74
9660951 - Mol Cell. 1998 Apr;1(5):673-83
F Ramirez (BFoncsis201329_CR27) 2009; 21
JJ Hulmi (BFoncsis201329_CR52) 2013; 304
H Lee (BFoncsis201329_CR41) 2007; 48
F Ramirez (BFoncsis201329_CR15) 2010; 339
J Brinckmann (BFoncsis201329_CR23) 2010; 90
K Koli (BFoncsis201329_CR16) 2006; 169
C Kosinski (BFoncsis201329_CR36) 2007; 104
D Fenyo (BFoncsis201329_CR51) 2010; 673
K Koli (BFoncsis201329_CR29) 2005; 310
Y Ke (BFoncsis201329_CR47) 1989; 134
O Leppäranta (BFoncsis201329_CR24) 2012; 348
A Fassina (BFoncsis201329_CR43) 2012; 25
KJ Gordon (BFoncsis201329_CR30) 2009; 30
G Sengle (BFoncsis201329_CR9) 2008; 283
LZ Topol (BFoncsis201329_CR11) 1997; 17
B Chen (BFoncsis201329_CR38) 2002; 295
S Mitola (BFoncsis201329_CR46) 2010; 116
BP Lanphear (BFoncsis201329_CR2) 1992; 34
G Lin (BFoncsis201329_CR26) 2002; 277
K Koli (BFoncsis201329_CR48) 2008; 43
BT Mossman (BFoncsis201329_CR1) 1990; 247
MH Kang (BFoncsis201329_CR31) 2011; 317
DR Hsu (BFoncsis201329_CR7) 1998; 1
V Dormoy (BFoncsis201329_CR5) 2012; 32
G Pasello (BFoncsis201329_CR45) 2013; 39
JY Shih (BFoncsis201329_CR42) 2011; 32
M Kim (BFoncsis201329_CR33) 2012; 7
H Namkoong (BFoncsis201329_CR12) 2006; 6
K Polyak (BFoncsis201329_CR21) 2009; 9
JB Sneddon (BFoncsis201329_CR35) 2007; 1
DS Micalizzi (BFoncsis201329_CR6) 2010; 15
DA Vorobiof (BFoncsis201329_CR4) 2009; 10
A Catalano (BFoncsis201329_CR18) 2004; 279
H Merikallio (BFoncsis201329_CR44) 2012; 121
M Varjosalo (BFoncsis201329_CR14) 2013; 10
AM Haslehurst (BFoncsis201329_CR19) 2012; 12
M Myllärniemi (BFoncsis201329_CR49) 2008; 177
T Glatter (BFoncsis201329_CR50) 2009; 5
DJ Wang (BFoncsis201329_CR22) 2012; 27
JP Thiery (BFoncsis201329_CR17) 2009; 139
MS Huuskonen (BFoncsis201329_CR3) 2006; 49
JA Tamminen (BFoncsis201329_CR53) 2012; 113
SL Dallas (BFoncsis201329_CR28) 2006; 75
S Kilpinen (BFoncsis201329_CR37) 2008; 9
H Wang (BFoncsis201329_CR39) 2012; 24
G Carvajal (BFoncsis201329_CR40) 2008; 40
Y Katsuno (BFoncsis201329_CR32) 2008; 27
SA Mani (BFoncsis201329_CR20) 2008; 133
O Michos (BFoncsis201329_CR10) 2004; 131
JB Sneddon (BFoncsis201329_CR13) 2006; 103
LZ Topol (BFoncsis201329_CR8) 2000; 275
MS Mulvihill (BFoncsis201329_CR34) 2012; 7
C Vancheri (BFoncsis201329_CR25) 2010; 35
References_xml – volume: 121
  start-page: 1
  year: 2012
  end-page: 10
  ident: CR44
  article-title: Expression of snail, twist, and Zeb1 in malignant mesothelioma
  publication-title: APMIS
  doi: 10.1111/j.1600-0463.2012.02931.x
  contributor:
    fullname: Soini
– volume: 32
  start-page: 3609
  year: 2012
  end-page: 3617
  ident: CR5
  article-title: From development to cancer: lessons from the kidney to uncover new therapeutic targets
  publication-title: Anticancer Res
  contributor:
    fullname: Massfelder
– volume: 139
  start-page: 871
  year: 2009
  end-page: 890
  ident: CR17
  article-title: Epithelial-mesenchymal transitions in development and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
  contributor:
    fullname: Nieto
– volume: 103
  start-page: 14842
  year: 2006
  end-page: 14847
  ident: CR13
  article-title: Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0606857103
  contributor:
    fullname: West
– volume: 27
  start-page: 6322
  year: 2008
  end-page: 6333
  ident: CR32
  article-title: Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway
  publication-title: Oncogene
  doi: 10.1038/onc.2008.232
  contributor:
    fullname: Iwase
– volume: 134
  start-page: 979
  year: 1989
  end-page: 991
  ident: CR47
  article-title: Establishment of a human mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma
  publication-title: Am J Pathol
  contributor:
    fullname: McMenamin
– volume: 48
  start-page: 4291
  year: 2007
  end-page: 4299
  ident: CR41
  article-title: The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.07-0086
  contributor:
    fullname: Kane
– volume: 131
  start-page: 3401
  year: 2004
  end-page: 3410
  ident: CR10
  article-title: antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis
  publication-title: Development
  doi: 10.1242/dev.01251
  contributor:
    fullname: Zuniga
– volume: 10
  start-page: 112
  year: 2009
  end-page: 117
  ident: CR4
  article-title: Malignant pleural mesothelioma: medical treatment update
  publication-title: Clin Lung Cancer
  doi: 10.3816/CLC.2009.n.014
  contributor:
    fullname: Mafafo
– volume: 279
  start-page: 46706
  year: 2004
  end-page: 46714
  ident: CR18
  article-title: Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M406696200
  contributor:
    fullname: Procopio
– volume: 317
  start-page: 1746
  year: 2011
  end-page: 1762
  ident: CR31
  article-title: Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2011.04.006
  contributor:
    fullname: Kim
– volume: 30
  start-page: 238
  year: 2009
  end-page: 248
  ident: CR30
  article-title: Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgn274
  contributor:
    fullname: Blobe
– volume: 32
  start-page: 1299
  year: 2011
  end-page: 1304
  ident: CR42
  article-title: The EMT regulator slug and lung carcinogenesis
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgr110
  contributor:
    fullname: Yang
– volume: 43
  start-page: 679
  year: 2008
  end-page: 688
  ident: CR48
  article-title: Latent TGF-β binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells
  publication-title: Bone
  doi: 10.1016/j.bone.2008.06.016
  contributor:
    fullname: Keski-Oja
– volume: 673
  start-page: 189
  year: 2010
  end-page: 202
  ident: CR51
  article-title: Mass spectrometric protein identification using the global proteome machine
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-60761-842-3_11
  contributor:
    fullname: Beavis
– volume: 7
  start-page: e42264
  year: 2012
  ident: CR34
  article-title: Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0042264
  contributor:
    fullname: Ray
– volume: 277
  start-page: 50795
  year: 2002
  end-page: 50804
  ident: CR26
  article-title: Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M210611200
  contributor:
    fullname: Brinckmann
– volume: 177
  start-page: 321
  year: 2008
  end-page: 329
  ident: CR49
  article-title: Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200706-945OC
  contributor:
    fullname: Keski-Oja
– volume: 17
  start-page: 4801
  year: 1997
  end-page: 4810
  ident: CR11
  article-title: Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.17.8.4801
  contributor:
    fullname: Clausen
– volume: 7
  start-page: e35100
  year: 2012
  ident: CR33
  article-title: Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0035100
  contributor:
    fullname: Kim
– volume: 104
  start-page: 15418
  year: 2007
  end-page: 15423
  ident: CR36
  article-title: Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0707210104
  contributor:
    fullname: Tsui
– volume: 21
  start-page: 616
  year: 2009
  end-page: 622
  ident: CR27
  article-title: Extracellular microfibrils: contextual platforms for TGFβ and BMP signaling
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2009.05.005
  contributor:
    fullname: Rifkin
– volume: 35
  start-page: 496
  year: 2010
  end-page: 504
  ident: CR25
  article-title: Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00077309
  contributor:
    fullname: Raghu
– volume: 247
  start-page: 294
  year: 1990
  end-page: 301
  ident: CR1
  article-title: Asbestos: scientific developments and implications for public policy
  publication-title: Science
  doi: 10.1126/science.2153315
  contributor:
    fullname: Gee
– volume: 10
  start-page: 307
  year: 2013
  end-page: 314
  ident: CR14
  article-title: Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2400
  contributor:
    fullname: Hauri
– volume: 116
  start-page: 3677
  year: 2010
  end-page: 3680
  ident: CR46
  article-title: Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2
  publication-title: Blood
  doi: 10.1182/blood-2010-06-291930
  contributor:
    fullname: Ballmer-Hofer
– volume: 27
  start-page: 58
  year: 2012
  end-page: 64
  ident: CR22
  article-title: The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma
  publication-title: Oncol Rep
  contributor:
    fullname: Han
– volume: 169
  start-page: 61
  year: 2006
  end-page: 71
  ident: CR16
  article-title: Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.051263
  contributor:
    fullname: Kinnula
– volume: 5
  start-page: 237
  year: 2009
  ident: CR50
  article-title: An integrated workflow for charting the human interaction proteome: insights into the PP2A system
  publication-title: Mol Syst Biol
  doi: 10.1038/msb.2008.75
  contributor:
    fullname: Gstaiger
– volume: 348
  start-page: 491
  year: 2012
  end-page: 503
  ident: CR24
  article-title: Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-012-1385-9
  contributor:
    fullname: Myllärniemi
– volume: 9
  start-page: R139
  year: 2008
  ident: CR37
  article-title: Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues
  publication-title: Genome Biol
  doi: 10.1186/gb-2008-9-9-r139
  contributor:
    fullname: Sara
– volume: 25
  start-page: 86
  year: 2012
  end-page: 99
  ident: CR43
  article-title: Epithelial-mesenchymal transition in malignant mesothelioma
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2011.144
  contributor:
    fullname: Ventura
– volume: 113
  start-page: 2234
  year: 2012
  end-page: 2247
  ident: CR53
  article-title: Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.24094
  contributor:
    fullname: Koli
– volume: 75
  start-page: 1
  year: 2006
  end-page: 24
  ident: CR28
  article-title: Dynamics of assembly and reorganization of extracellular matrix proteins
  publication-title: Curr Top Dev Biol
  doi: 10.1016/S0070-2153(06)75001-3
  contributor:
    fullname: Sivakumar
– volume: 295
  start-page: 1135
  year: 2002
  end-page: 1141
  ident: CR38
  article-title: Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(02)00828-8
  contributor:
    fullname: Blair
– volume: 339
  start-page: 71
  year: 2010
  end-page: 82
  ident: CR15
  article-title: Biogenesis and function of fibrillin assemblies
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-009-0822-x
  contributor:
    fullname: Sakai
– volume: 9
  start-page: 265
  year: 2009
  end-page: 273
  ident: CR21
  article-title: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2620
  contributor:
    fullname: Weinberg
– volume: 283
  start-page: 13874
  year: 2008
  end-page: 13888
  ident: CR9
  article-title: Targeting of bone morphogenetic protein growth factor complexes to fibrillin
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M707820200
  contributor:
    fullname: Keene
– volume: 39
  start-page: 10
  year: 2013
  end-page: 17
  ident: CR45
  article-title: An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2012.03.001
  contributor:
    fullname: Favaretto
– volume: 40
  start-page: 734
  year: 2008
  end-page: 739
  ident: CR40
  article-title: Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2008.02.064
  contributor:
    fullname: Flores
– volume: 90
  start-page: 739
  year: 2010
  end-page: 752
  ident: CR23
  article-title: Enhanced fibrillin-2 expression is a general feature of wound healing and sclerosis: potential alteration of cell attachment and storage of TGF-β
  publication-title: Lab Invest
  doi: 10.1038/labinvest.2010.49
  contributor:
    fullname: Gibson
– volume: 304
  start-page: E41
  year: 2013
  end-page: E50
  ident: CR52
  article-title: Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00389.2012
  contributor:
    fullname: Pierre
– volume: 1
  start-page: 673
  year: 1998
  end-page: 683
  ident: CR7
  article-title: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(00)80067-2
  contributor:
    fullname: Harland
– volume: 133
  start-page: 704
  year: 2008
  end-page: 715
  ident: CR20
  article-title: The epithelial-mesenchymal transition generates cells with properties of stem cells
  publication-title: Cell
  doi: 10.1016/j.cell.2008.03.027
  contributor:
    fullname: Zhou
– volume: 15
  start-page: 117
  year: 2010
  end-page: 134
  ident: CR6
  article-title: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression
  publication-title: J Mammary Gland Biol Neoplasia
  doi: 10.1007/s10911-010-9178-9
  contributor:
    fullname: Ford
– volume: 6
  start-page: 74
  year: 2006
  ident: CR12
  article-title: The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-6-74
  contributor:
    fullname: Hur
– volume: 12
  start-page: 91
  year: 2012
  ident: CR19
  article-title: EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-91
  contributor:
    fullname: Geraci
– volume: 310
  start-page: 370
  year: 2005
  end-page: 382
  ident: CR29
  article-title: Sequential deposition of latent TGF-β binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2005.08.008
  contributor:
    fullname: Keski-Oja
– volume: 24
  start-page: 17
  year: 2012
  end-page: 24
  ident: CR39
  article-title: Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2011.08.010
  contributor:
    fullname: Jiang
– volume: 275
  start-page: 8785
  year: 2000
  end-page: 8793
  ident: CR8
  article-title: Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.12.8785
  contributor:
    fullname: Marx
– volume: 34
  start-page: 718
  year: 1992
  end-page: 721
  ident: CR2
  article-title: Latent period for malignant mesothelioma of occupational origin
  publication-title: J Occup Med
  contributor:
    fullname: Buncher
– volume: 49
  start-page: 215
  year: 2006
  end-page: 220
  ident: CR3
  article-title: Finnish Institute of Occupational Health (FIOH): prevention and detection of asbestos-related diseases, 1987-2005
  publication-title: Am J Ind Med
  doi: 10.1002/ajim.20282
  contributor:
    fullname: Rantanen
– volume: 1
  start-page: 607
  year: 2007
  end-page: 611
  ident: CR35
  article-title: Location, location, location: the cancer stem cell niche
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.11.009
  contributor:
    fullname: Werb
– volume: 12
  start-page: 91
  year: 2012
  ident: BFoncsis201329_CR19
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-91
  contributor:
    fullname: AM Haslehurst
– volume: 40
  start-page: 734
  year: 2008
  ident: BFoncsis201329_CR40
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2008.02.064
  contributor:
    fullname: G Carvajal
– volume: 32
  start-page: 3609
  year: 2012
  ident: BFoncsis201329_CR5
  publication-title: Anticancer Res
  contributor:
    fullname: V Dormoy
– volume: 17
  start-page: 4801
  year: 1997
  ident: BFoncsis201329_CR11
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.17.8.4801
  contributor:
    fullname: LZ Topol
– volume: 177
  start-page: 321
  year: 2008
  ident: BFoncsis201329_CR49
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200706-945OC
  contributor:
    fullname: M Myllärniemi
– volume: 25
  start-page: 86
  year: 2012
  ident: BFoncsis201329_CR43
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2011.144
  contributor:
    fullname: A Fassina
– volume: 304
  start-page: E41
  year: 2013
  ident: BFoncsis201329_CR52
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00389.2012
  contributor:
    fullname: JJ Hulmi
– volume: 247
  start-page: 294
  year: 1990
  ident: BFoncsis201329_CR1
  publication-title: Science
  doi: 10.1126/science.2153315
  contributor:
    fullname: BT Mossman
– volume: 5
  start-page: 237
  year: 2009
  ident: BFoncsis201329_CR50
  publication-title: Mol Syst Biol
  doi: 10.1038/msb.2008.75
  contributor:
    fullname: T Glatter
– volume: 9
  start-page: R139
  year: 2008
  ident: BFoncsis201329_CR37
  publication-title: Genome Biol
  doi: 10.1186/gb-2008-9-9-r139
  contributor:
    fullname: S Kilpinen
– volume: 24
  start-page: 17
  year: 2012
  ident: BFoncsis201329_CR39
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2011.08.010
  contributor:
    fullname: H Wang
– volume: 310
  start-page: 370
  year: 2005
  ident: BFoncsis201329_CR29
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2005.08.008
  contributor:
    fullname: K Koli
– volume: 103
  start-page: 14842
  year: 2006
  ident: BFoncsis201329_CR13
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0606857103
  contributor:
    fullname: JB Sneddon
– volume: 317
  start-page: 1746
  year: 2011
  ident: BFoncsis201329_CR31
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2011.04.006
  contributor:
    fullname: MH Kang
– volume: 9
  start-page: 265
  year: 2009
  ident: BFoncsis201329_CR21
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2620
  contributor:
    fullname: K Polyak
– volume: 48
  start-page: 4291
  year: 2007
  ident: BFoncsis201329_CR41
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.07-0086
  contributor:
    fullname: H Lee
– volume: 275
  start-page: 8785
  year: 2000
  ident: BFoncsis201329_CR8
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.12.8785
  contributor:
    fullname: LZ Topol
– volume: 35
  start-page: 496
  year: 2010
  ident: BFoncsis201329_CR25
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00077309
  contributor:
    fullname: C Vancheri
– volume: 75
  start-page: 1
  year: 2006
  ident: BFoncsis201329_CR28
  publication-title: Curr Top Dev Biol
  doi: 10.1016/S0070-2153(06)75001-3
  contributor:
    fullname: SL Dallas
– volume: 1
  start-page: 673
  year: 1998
  ident: BFoncsis201329_CR7
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(00)80067-2
  contributor:
    fullname: DR Hsu
– volume: 49
  start-page: 215
  year: 2006
  ident: BFoncsis201329_CR3
  publication-title: Am J Ind Med
  doi: 10.1002/ajim.20282
  contributor:
    fullname: MS Huuskonen
– volume: 339
  start-page: 71
  year: 2010
  ident: BFoncsis201329_CR15
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-009-0822-x
  contributor:
    fullname: F Ramirez
– volume: 10
  start-page: 112
  year: 2009
  ident: BFoncsis201329_CR4
  publication-title: Clin Lung Cancer
  doi: 10.3816/CLC.2009.n.014
  contributor:
    fullname: DA Vorobiof
– volume: 131
  start-page: 3401
  year: 2004
  ident: BFoncsis201329_CR10
  publication-title: Development
  doi: 10.1242/dev.01251
  contributor:
    fullname: O Michos
– volume: 1
  start-page: 607
  year: 2007
  ident: BFoncsis201329_CR35
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.11.009
  contributor:
    fullname: JB Sneddon
– volume: 21
  start-page: 616
  year: 2009
  ident: BFoncsis201329_CR27
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2009.05.005
  contributor:
    fullname: F Ramirez
– volume: 277
  start-page: 50795
  year: 2002
  ident: BFoncsis201329_CR26
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M210611200
  contributor:
    fullname: G Lin
– volume: 279
  start-page: 46706
  year: 2004
  ident: BFoncsis201329_CR18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M406696200
  contributor:
    fullname: A Catalano
– volume: 295
  start-page: 1135
  year: 2002
  ident: BFoncsis201329_CR38
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(02)00828-8
  contributor:
    fullname: B Chen
– volume: 32
  start-page: 1299
  year: 2011
  ident: BFoncsis201329_CR42
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgr110
  contributor:
    fullname: JY Shih
– volume: 15
  start-page: 117
  year: 2010
  ident: BFoncsis201329_CR6
  publication-title: J Mammary Gland Biol Neoplasia
  doi: 10.1007/s10911-010-9178-9
  contributor:
    fullname: DS Micalizzi
– volume: 43
  start-page: 679
  year: 2008
  ident: BFoncsis201329_CR48
  publication-title: Bone
  doi: 10.1016/j.bone.2008.06.016
  contributor:
    fullname: K Koli
– volume: 7
  start-page: e35100
  year: 2012
  ident: BFoncsis201329_CR33
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0035100
  contributor:
    fullname: M Kim
– volume: 27
  start-page: 6322
  year: 2008
  ident: BFoncsis201329_CR32
  publication-title: Oncogene
  doi: 10.1038/onc.2008.232
  contributor:
    fullname: Y Katsuno
– volume: 348
  start-page: 491
  year: 2012
  ident: BFoncsis201329_CR24
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-012-1385-9
  contributor:
    fullname: O Leppäranta
– volume: 113
  start-page: 2234
  year: 2012
  ident: BFoncsis201329_CR53
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.24094
  contributor:
    fullname: JA Tamminen
– volume: 90
  start-page: 739
  year: 2010
  ident: BFoncsis201329_CR23
  publication-title: Lab Invest
  doi: 10.1038/labinvest.2010.49
  contributor:
    fullname: J Brinckmann
– volume: 30
  start-page: 238
  year: 2009
  ident: BFoncsis201329_CR30
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgn274
  contributor:
    fullname: KJ Gordon
– volume: 116
  start-page: 3677
  year: 2010
  ident: BFoncsis201329_CR46
  publication-title: Blood
  doi: 10.1182/blood-2010-06-291930
  contributor:
    fullname: S Mitola
– volume: 34
  start-page: 718
  year: 1992
  ident: BFoncsis201329_CR2
  publication-title: J Occup Med
  contributor:
    fullname: BP Lanphear
– volume: 10
  start-page: 307
  year: 2013
  ident: BFoncsis201329_CR14
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2400
  contributor:
    fullname: M Varjosalo
– volume: 39
  start-page: 10
  year: 2013
  ident: BFoncsis201329_CR45
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2012.03.001
  contributor:
    fullname: G Pasello
– volume: 283
  start-page: 13874
  year: 2008
  ident: BFoncsis201329_CR9
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M707820200
  contributor:
    fullname: G Sengle
– volume: 139
  start-page: 871
  year: 2009
  ident: BFoncsis201329_CR17
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
  contributor:
    fullname: JP Thiery
– volume: 27
  start-page: 58
  year: 2012
  ident: BFoncsis201329_CR22
  publication-title: Oncol Rep
  contributor:
    fullname: DJ Wang
– volume: 104
  start-page: 15418
  year: 2007
  ident: BFoncsis201329_CR36
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0707210104
  contributor:
    fullname: C Kosinski
– volume: 121
  start-page: 1
  year: 2012
  ident: BFoncsis201329_CR44
  publication-title: APMIS
  doi: 10.1111/j.1600-0463.2012.02931.x
  contributor:
    fullname: H Merikallio
– volume: 673
  start-page: 189
  year: 2010
  ident: BFoncsis201329_CR51
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-60761-842-3_11
  contributor:
    fullname: D Fenyo
– volume: 169
  start-page: 61
  year: 2006
  ident: BFoncsis201329_CR16
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.051263
  contributor:
    fullname: K Koli
– volume: 133
  start-page: 704
  year: 2008
  ident: BFoncsis201329_CR20
  publication-title: Cell
  doi: 10.1016/j.cell.2008.03.027
  contributor:
    fullname: SA Mani
– volume: 6
  start-page: 74
  year: 2006
  ident: BFoncsis201329_CR12
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-6-74
  contributor:
    fullname: H Namkoong
– volume: 134
  start-page: 979
  year: 1989
  ident: BFoncsis201329_CR47
  publication-title: Am J Pathol
  contributor:
    fullname: Y Ke
– volume: 7
  start-page: e42264
  year: 2012
  ident: BFoncsis201329_CR34
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0042264
  contributor:
    fullname: MS Mulvihill
SSID ssj0000561655
Score 2.1449354
Snippet Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e66
SubjectTerms 631/67/1059/602
631/67/1641
692/420/755
Apoptosis
Cell Biology
Human Genetics
Internal Medicine
Medicine
Medicine & Public Health
Oncology
Original
original-article
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS91AEB7qEcSXovXSVFtWEPRlNcluLvtUWlGkoEhR8C3sbjZ6wJNYc45_wD_uTLI59VIKeVmyIdmd2ZlvLpkB2BUuV1aaiDuhLUeNH3MllONCqCQxWlRlFzE9O09Pr-Sv6-TaO9xan1Y5yMROUJeNJR_5YYS2GupGVFDf7_9w6hpF0VXfQmMBFmO0FMIRLP48Pr_4PfeyED5Ok2So1ijyw6a27ZjqdEfioMOVL7TRO4j5PlPyTbi000InK_DRw0f2o6f3Knxw9SdYOvMB8jV4QpN_gsiRR0z7jXctI2crqyi5nypwswkl4fXDluH4cfzYMF2X7KFvTI9PTFxLv2bdjZuJZuTcZ-0MhQqyJfOdfdiUtNwgc1jft4e1d7Obdbg8Ob48OuW-zwK3UkVTbkyFR9OpvIrTxCGBhEHcWEohQ5lZ5ZRBFKVDG-lM58qFlcRLhprMDYQIYgNGdVO7z8Ay5UpZprZMcoPIxOTGGoRIkalygpYqgL1hu4v7vppG0UXBRV70hCmIMEWMM7cHahT-VLXFXx4IYGd-G88D7YOuXTOjOYq62IQiDmCzJ978VTGCLxSqaQDZK7LOJ1Ct7dd36vFtV3NbZIlCVR7A_sAALz7rnyv48v8VbMFy3HXWoFzCbRhNH2buK-KbqfnmmfgZ0RUAvA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB4BlRAXBC0tAYqMVKlcTJPYefiAUIV4CAlOIHGL7MRpV9pN2s0ugjN_nJk42bJdDki5WHESxzP2fGOP5wP4JmyqcmkCboXOOVr8kCuhLBdCRZHRoizaHdPrm_jyTl7dR_f_4p-6DmzedO2IT-puPDx6_Pt0ggP-2B0ZT3_UVd4MKPV2II5CtQwfQoleOoXxdVDf5fmOg7glQUUjl3CFtqnP4bjwinkbtQA8F-Mn_9tEbW3T-Qasd6CS_XRasAlLtvoIq9fdtvkneL4Y2xHiSR4w3YnDNoyWYFlJIf-Ul5uNKDTPFRuG5YfBQ810VbCxo6vHJ0a2oQNbw0E90oyW_FkzxakGlZV1fD9sQravn4mYY_NhzXD6awtuz89uTy95x77Ac6mCCTemxAFrVVqGcWRRbMIgmiykkL5McmWVQWyl_TzQiU6V9UuJl_Q1OSEIHMRnWKnqym4DS5QtZBHnRZQaxCsmNblB4BSYMiXAqTz43nd39sfl2MjavXGRZk4wGQkmC7HmXi-NrFeVLEAvHlETQhcPDma3cZRQP-jK1lOqo4jbxhehB1-c8GafChGS4VQbe5DMiXVWgTJwz9-pBr_bTNwiiRQaeA8OewV41aw3_2DnHU3chbWwJd2gMMM9WJmMp_YrQp-J2W91-gXgBwa1
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer_OA刊
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEB58gHgR31ZXiSDopdo2aZscZVFE0NMKeytJm-rCbit21z_gH3emj8V1PQi9hExom5lkvslMZgAuuJUqFcZ3Ldepixo_cBVX1uVchaHRPM9qj-nTc_TwIh6H4bANkKW7MAv-ey5vyiKtRpRW2-fXgVqFddS_kkK3-lF_fpZCKDgKwy4n49KwRZ2zBCSX4yF_OUVrXXO_DVstSGS3DVd3YMUWu7Dx1LrB9-ALDfsJ4kPXZ7qdXlsxOlJlOYXwU55tNqFQu6ZZMWx_jj5LpouMfTTl53HExFZ0AWs8Kiea0RE-q2a4daDwsbZ-D5uSLut2FtZU52HVePa6D4P7u0H_wW2rKbipUP7UNSbHBWiVzIMotMgGbhAdZoILT8SpssogVtJe6utYS2W9XOAjPE1GBQIBfgBrRVnYI2CxspnIojQLpUH8YaRJDQIh3-SSAKRy4LKb7uS9yZmR1L5uLpOGMQkxJgmQstdxI2nXTpX4aJUjCkIo4sD5vBulnuZBF7acEY2iWjUeDxw4bJg3f1WAEAu3zsiBeIGtcwLKqL3YU4ze6szaPA4VKmwHrjoB-PFZf_7B8f9JT2AzqGtpUPRgD9amHzN7iohmas5qcf4GkR34mQ
  priority: 102
  providerName: Springer Nature
Title Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug
URI https://link.springer.com/article/10.1038/oncsis.2013.29
https://www.ncbi.nlm.nih.gov/pubmed/23978876
https://www.proquest.com/docview/1788355151
https://search.proquest.com/docview/1790961032
https://pubmed.ncbi.nlm.nih.gov/PMC3759128
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swED_aDsZexrp_ddcFDQbbixPbkmzpcQstpZBSRgd5M5Isb4bYLnXSL7Av3pNsh2btU8EYhGQk6-50P-lOdwBfqRXSMB2HlioTosZPQkmlDSmVnGtFy8JbTBeX6flvdrHkyz3g410Y77RvdDVtVvW0qf5638qb2sxGP7HZ1WJOMy5xXZ3twz4y6IMteh_QO41TzscAjVTM2sZ0lQvNHdNp4sKEJqiEUbjSXV30CGA-9pP8z1jqddDZG3g9gEfyox_kIezZ5i28XAzm8XfwDzf8NeLGMCZqmHbbEXfUSkrn2u_ib5PaueD1xY5g-a66a4lqCnLbp6XHL2rbuYtZq6qtFXFH-6Tb4JKCTEmGvD5k7XTcuOKQPmsP6VabP-_h-uz0en4eDlkWQsNkvA61LlEwrRRlknKL5KEaUWPBKItYZqSVGjGUikysMiWkjUqGD4uU22wgQKAf4KBpG3sEJJO2YEVqCi404hIttNEIkGJdCgcsZQDfxunOb_pYGrm3gVOR9zTKHY3yBFuejNTIB5nq8hhphugIIUoAX7bVKA1uHlRj241rI10Om4gmAXzsibftaqR6ANkOWbcNXKTt3RpkQB9xe2C4AL6PDPBgWE_-wfGzO_kErxKfcsM5GZ7Awfp2Yz8j8FnrCbL7MpvAi5-nl1e_sDRP5xN_iIDvBRMTLwj3lkMNlg
link.rule.ids 230,315,730,783,787,867,888,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,41132,42201,43322,43817,51588,53804,53806,74079,74636
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RItFeEI8WUgoYCYle3E1i5-ETQohqgW5Pi7S3yHacdqVu0ja7_QP948wkztKXkHKx4iixx575PDOZD-CzcLmy0kTcCW05WvyYK6EcF0IlidGiKruI6eQkHf-Rv2bJzDvcWp9WOejETlGXjSUf-SjCsxraRjRQXy8uObFGUXTVU2hswFOqw0UMBtksW_tYCB2nSTLUahT5qKltO6cq3ZE47FDlLVv0AGA-zJO8FyztbNDRC3juwSP71kv7JTxx9St4NvHh8ddwgwf-BeJGHjHtp921jFytrKLUfqq_zRaUgtc3W4bt6_l1w3Rdsquelh6fWLiWfsw6nzcLzci1z9oVqhRclMzz-rAl2bhB47CetYe156vTHZge_Zh-H3PPssCtVNGSG1PhxnQqr-I0cSgeYRA1llLIUGZWOWUQQ-nQRjrTuXJhJfGSoabDBgIEsQubdVO7t8Ay5UpZprZMcoO4xOTGGgRIkalyApYqgC_DdBcXfS2NoouBi7zoBVOQYIoYe-4P0ij8nmqLfysggE_r27gbaB507ZoV9VHEYROKOIA3vfDWr4oReqFKTQPI7oh13YEqbd-9U8_PuorbIksUGvIADoYFcOuzHh3B3v9H8BG2xtPJcXH88-T3O9iOO44Nyirch83l1cq9R6SzNB-65fwXxNgCRw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VKiEuqA9KA7Q1UiW4uJvEzsOnqmq7oqUgDiDtLbIdh67EJkB2-QP9451JnC0vVcrFiqPEnvHMN4_MAHwULldWmog7oS1HjR9zJZTjQqgkMVpUZRcxPT5JD8_lz0ky8flPrU-rHGRiJ6jLxpKPfBShrYa6ERXUqPJpEaffxp-vrjl1kKJIq2-nsQLPM7RSiMOzSbb0txBSTpNkqNso8lFT23ZKFbsj8alDmHf00iOw-Thn8kHgtNNH4xew4YEk-9JT_iU8c_UrWDv2ofLX8AeN_xliSB4x7UngWkZuV1ZRmj_V4mYzSsfrhy3D8e30tmG6LtlN36Ien5i5ln7Supw2M83Izc_aBYoXZFDme_ywOem7QfqwvoMPay8XF5twNv5-9vWQ-44L3EoVzbkxFR5Sp_IqThOHpBIGEWQphQxlZpVTBvGUDm2kM50rF1YSLxlqMjwQLIg3sFo3tXsLLFOulGVqyyQ3iFFMbqxBsBSZKieQqQLYH7a7uOrrahRdPFzkRU-YgghTxDhzd6BG4c9XW_zjhgD2lrfxZNA-6No1C5qjqJ9NKOIAtnriLV8VIwxD8ZoGkN0j63ICVd2-f6ee_u6qb4ssUajUAzgYGODOZz25gu3_r-ADrCEnF79-nBztwHrctdugBMNdWJ3fLNw7BD1z877j5r-jlgaF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gremlin-1+associates+with+fibrillin+microfibrils+in+vivo+and+regulates+mesothelioma+cell+survival+through+transcription+factor+slug&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Tamminen%2C+J+A&rft.au=Parviainen%2C+V&rft.au=Ronty%2C+M&rft.au=Wohl%2C+A+P&rft.date=2013-08-01&rft.issn=2157-9024&rft.eissn=2157-9024&rft.volume=2&rft.spage=e66&rft.epage=e66&rft_id=info:doi/10.1038%2Foncsis.2013.29&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon